Figure 3

Temporal analysis. Differences in evolution for circulating biomarkers in patients with (red) or without (blue) PGD3 at T48–72 h in the full and overlap weighted cohort are shown. The overlap weighted cohort was adjusted for the following factors: BMI, hypertension, type of transplant, EVLP, and type of ECLS. (A) Macrophage inflammatory protein (MIP)-1B, (B) interleukin (IL)-9, and (C) interleukin-1 receptor antagonist (IL-1Ra). Circles represent the average biomarker level at respective time points; dotted lines represent 95% confidence intervals for the biomarker level at respective time points. The image was created using R software version number 4.1.3 (https://cran.r-project.org).